Diabetes Linked to Bile Duct Cancer Risk in Latin America

What Was Studied and Why It Matters

Researchers across five major medical centers in Latin America tracked 309 patients diagnosed with cholangiocarcinoma (CCA) — a cancer of the bile ducts — between 2010 and 2023. While CCA may sound unrelated to diabetes, this study is important for the diabetes community because diabetes was identified as one of the major risk factors for developing this cancer. Understanding that connection can help people with diabetes and their caregivers take a more proactive approach to their overall health.

What the Study Found

The research uncovered several important findings:

• Diabetes is a key risk factor. Along with obesity, age, fatty liver disease (MASLD), gallstones, and gallbladder inflammation, diabetes was flagged as a leading contributor to CCA development.
• Most patients were diagnosed late. Only 47% of patients had localized (early-stage) disease at diagnosis. A full 34% already had metastatic (widely spread) cancer by the time they were identified.
• Survival depended heavily on treatment. Patients who received no treatment survived a median of just 2.3 months. Surgery offered the best outcomes at 34 months, while chemotherapy extended survival to about 8 months.
• Ethnic disparities were stark. African-descent patients tended to present with more advanced disease and worse overall health status at diagnosis. Hispanic patients were less frequently offered chemotherapy for advanced disease, resulting in survival rates of only 6 months compared to 12.6 months among Caucasian patients.
• Obesity and overweight were more common in Hispanic and Caucasian patients, and in those with cancers affecting the external bile ducts — a pattern that links metabolic health directly to cancer risk.

What This Means for Diabetes Patients

If you are living with type 2 diabetes, you may already know that your condition increases the risk of several other serious health issues. This study adds bile duct cancer to that list. The good news is that many of the risk factors identified — obesity, fatty liver disease, and poorly controlled blood sugar — are manageable with the right tools and support.

Staying consistent with your diabetes management matters more than ever. That includes monitoring your blood glucose regularly, maintaining a healthy weight, and keeping up with routine medical check-ups. Reliable supplies play a role here too — whether it is your glucose meter, test strips, or continuous glucose monitoring (CGM) system, having dependable access to the right tools through a trusted provider like MDS Diabetes makes daily management easier and more consistent.

If you have diabetes alongside obesity, fatty liver disease, or a history of gallstones, speak with your doctor about whether additional screening or monitoring may be appropriate for you.

A Note on Health Equity

This study raises serious concerns about unequal access to cancer care across ethnic and socioeconomic groups in Latin America. Researchers are calling for better cancer screening programs, greater awareness among high-risk populations, and fairer healthcare coverage. These same principles apply broadly — equitable access to quality diabetes supplies and care is essential for everyone managing a chronic condition.

Bottom Line

Diabetes is a recognized risk factor for a rare but aggressive bile duct cancer. Late diagnoses and unequal access to treatment are costing lives, especially among minority populations. Managing your diabetes well — with consistent monitoring and quality supplies — is one of the most powerful steps you can take to protect your long-term health.